Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Mai EK"'
Autor:
Werly A; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Hampel M; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Hielscher T; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Zuern K; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Schmidt SK; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Visram A; Division of Haematology, The Ottawa Hospital, Ottawa, Canada., Raab MS; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Mueller-Tidow C; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Goldschmidt H; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany., Mai EK; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany. elias.mai@med.uni-heidelberg.de.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2024 Oct 14; Vol. 14 (1), pp. 176. Date of Electronic Publication: 2024 Oct 14.
Autor:
Frenking JH; Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg, Baden-Württemberg, Germany jan.frenking@med.uni-heidelberg.de.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Baden-Württemberg, Germany., Zhou X; Internal Medicine II, University Hospital of Würzburg, Würzburg, Bayern, Germany., Wagner V; Internal Medicine II, University Hospital of Würzburg, Würzburg, Bayern, Germany., Hielscher T; Division of Biostatistics, German Cancer Research Center, Heidelberg, Baden-Württemberg, Germany., Kauer J; Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg, Baden-Württemberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Baden-Württemberg, Germany., Mai EK; Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg, Baden-Württemberg, Germany., Friedrich MJ; Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg, Baden-Württemberg, Germany.; Eli and Edythe L Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA., Michel CS; Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg, Baden-Württemberg, Germany., Hajiyianni M; Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg, Baden-Württemberg, Germany., Breitkreutz I; Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg, Baden-Württemberg, Germany., Costello P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Nadeem O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Weinhold N; Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg, Baden-Württemberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Baden-Württemberg, Germany., Goldschmidt H; Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg, Baden-Württemberg, Germany.; National Center for Tumor Diseases, Heidelberg, Baden-Württemberg, Germany., Schmitt A; Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg, Baden-Württemberg, Germany., Luft T; Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg, Baden-Württemberg, Germany., Schmitt M; Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg, Baden-Württemberg, Germany., Müller-Tidow C; Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg, Baden-Württemberg, Germany.; National Center for Tumor Diseases, Heidelberg, Baden-Württemberg, Germany., Topp M; Internal Medicine II, University Hospital of Würzburg, Würzburg, Bayern, Germany., Einsele H; Internal Medicine II, University Hospital of Würzburg, Würzburg, Bayern, Germany., Dreger P; Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg, Baden-Württemberg, Germany., Munshi NC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Sperling AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Hematology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Rasche L; Internal Medicine II, University Hospital of Würzburg, Würzburg, Bayern, Germany., Sauer S; Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg, Baden-Württemberg, Germany., Raab MS; Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg, Baden-Württemberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Baden-Württemberg, Germany.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Oct 07; Vol. 12 (10). Date of Electronic Publication: 2024 Oct 07.
Autor:
Mai EK; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg 69120, Germany. Electronic address: elias.mai@med.uni-heidelberg.de.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2024 Sep 06. Date of Electronic Publication: 2024 Sep 06.
Autor:
Maura F, Kaddoura M, Poos AM, Baughn LB, Ziccheddu B, Bärtsch MA, Cirrincione A, Maclachlan K, Chojnacka M, Diamond B, Papadimitriou M, Blaney P, John L, Reichert P, Huhn S, Gagler D, Zhang Y, Dogan A, Lesokhin AM, Davies F, Goldschmidt H, Fenk R, Weisel KC, Mai EK, Korde N, Morgan GJ, Rajkumar SV, Kumar S, Usmani S, Landgren O, Raab MS, Weinhold N
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Sep 04. Date of Electronic Publication: 2024 Sep 04.
Autor:
Zuern K; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Hielscher T; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Werly A; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Breitkreutz I; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Sauer S; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Raab MS; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Müller-Tidow C; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Goldschmidt H; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Mai EK; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany. elias.mai@med.uni-heidelberg.de.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2024 Aug 27; Vol. 14 (1), pp. 148. Date of Electronic Publication: 2024 Aug 27.
Autor:
Cirrincione AM; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Poos AM; Heidelberg Myeloma Center, Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Ziccheddu B; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Kaddoura M; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Bärtsch MA; Heidelberg Myeloma Center, Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Maclachlan K; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Chojnacka M; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Diamond B; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., John L; Heidelberg Myeloma Center, Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Reichert P; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Huhn S; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Blaney P; Myeloma Research Program, New York University Langone, Perlmutter Cancer Center, New York, NY., Gagler D; Myeloma Research Program, New York University Langone, Perlmutter Cancer Center, New York, NY., Rippe K; Division of Chromatin Networks, German Cancer Research Center and BioQuant, Heidelberg, Germany., Zhang Y; Cytogenetics Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY., Dogan A; Hematopathology Service, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY., Lesokhin AM; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Davies F; Myeloma Research Program, New York University Langone, Perlmutter Cancer Center, New York, NY., Goldschmidt H; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Fenk R; Department of Hematology, Oncology and Clinical Immunology, University-Hospital Duesseldorf, Duesseldorf, Germany., Weisel KC; Department of Oncology, Hematology, and Blood and Marrow Transplant, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Mai EK; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Korde N; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Morgan GJ; Myeloma Research Program, New York University Langone, Perlmutter Cancer Center, New York, NY., Usmani S; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Landgren O; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Raab MS; Heidelberg Myeloma Center, Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Weinhold N; Heidelberg Myeloma Center, Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Maura F; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.
Publikováno v:
Blood [Blood] 2024 Aug 15; Vol. 144 (7), pp. 771-783.
Autor:
Sachpekidis C; Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69210, Heidelberg, Germany. c.sachpekidis@dkfz-heidelberg.de., Enqvist O; Eigenvision AB, Malmö, Sweden.; Department of Electrical Engineering, Chalmers University of Technology, Gothenburg, Sweden., Ulén J; Eigenvision AB, Malmö, Sweden., Kopp-Schneider A; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Pan L; Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69210, Heidelberg, Germany., Mai EK; Department of Internal Medicine V, University Hospital Heidelberg and National Center for Tumor Diseases (NCT), Heidelberg, Germany., Hajiyianni M; Department of Internal Medicine V, University Hospital Heidelberg and National Center for Tumor Diseases (NCT), Heidelberg, Germany., Merz M; Department of Hematology and Cell Therapy, University of Leipzig, Leipzig, Germany., Raab MS; Department of Internal Medicine V, University Hospital Heidelberg and National Center for Tumor Diseases (NCT), Heidelberg, Germany., Jauch A; Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany., Goldschmidt H; Department of Internal Medicine V, University Hospital Heidelberg and National Center for Tumor Diseases (NCT), Heidelberg, Germany., Edenbrandt L; Department of Clinical Physiology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Dimitrakopoulou-Strauss A; Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69210, Heidelberg, Germany.
Publikováno v:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Jul; Vol. 51 (8), pp. 2293-2307. Date of Electronic Publication: 2024 Mar 08.
Autor:
Kriegsmann K; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Laborarztpraxis Rhein-Main MVZ GbR, Frankfurt am Main, Germany., Ton GNHQ; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Awwad MHS; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Benner A; Division of Biostatistics, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany., Bertsch U; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases Heidelberg, Heidelberg, Germany., Besemer B; Department of Internal Medicine II, University Hospital Tübingen, Tübingen, Germany., Hänel M; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany., Fenk R; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany., Munder M; Department of Internal Medicine III, University Hospital Mainz, Mainz, Germany., Dürig J; Department for Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany., Blau IW; Medical Clinic, Charité University Medicine Berlin, Berlin, Germany., Huhn S; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Hose D; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Jauch A; Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany., Mann C; Department of Hematology, Oncology and Immunology, Phillips-University Marburg, Marburg, Germany., Weinhold N; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Scheid C; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany., Schroers R; Department of Hematology, Oncology, Ruhr-University Bochum, Bochum, Germany., von Metzler I; Department of Internal Medicine II, University Hospital Frankfurt a.M., Frankfurt a.M., Germany., Schieferdecker A; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Thomalla J; Hematology/Oncology Center, Koblenz, Germany., Reimer P; Evang. Kliniken Essen-Mitte, Evang. Krankenhaus Essen-Werden, Essen, Germany., Mahlberg R; Internal Medicine I, Hospital Mutterhaus der Borromäerinnen, Trier, Germany., Graeven U; Department of Hematology, Oncology and Gastroenterology, Kliniken Maria Hilf GmbH, Mönchengladbach, Germany., Kremers S; Hematology/Oncology Center, Lebach, Germany., Martens UM; Hematology, Oncology, Palliative Care, SLK Clinics Heilbronn, Heilbronn, Germany., Kunz C; Hematology and Oncology, Westpfalz-Klinikum, Kaiserslautern, Germany., Hensel M; Mannheimer Onkologie Praxis, Mannheim, Germany., Seidel-Glätzer A; Coordination Centre for Clinical Trials (KKS) Heidelberg, Heidelberg, Germany., Weisel KC; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Salwender HJ; Asklepios Tumorzentrum Hamburg, Asklepios Hospital Hamburg Altona and St. Georg, Hamburg, Germany., Müller-Tidow C; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases Heidelberg, Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), University of Heidelberg and European Molecular Biology Laboratory (EMBL), Heidelberg, Germany., Raab MS; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Goldschmidt H; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases Heidelberg, Heidelberg, Germany., Mai EK; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Hundemer M; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany. michael.hundemer@med.uni-heidelberg.de.
Publikováno v:
Leukemia [Leukemia] 2024 Jul; Vol. 38 (7), pp. 1621-1625. Date of Electronic Publication: 2024 Jun 03.
Autor:
Schreiner S; Medical Department V, Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany., Berghaus N; Medical Department V, Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany., Poos AM; Medical Department V, Heidelberg Myeloma Center, Heidelberg University Hospital, Germany., Raab MS; Medical Department V, Heidelberg Myeloma Center, Heidelberg University Hospital, National Centre for Tumor Diseases (NCT), Heidelberg, Germany., Besemer B; Department of Internal Medicine II, Tübingen University Hospital, Tübingen, Germany., Fenk R; Department of Hematology, Oncology, and Clinical Immunology, Düsseldorf University Hospital, Düsseldorf, Germany., Goldschmidt H; Medical Department V, Heidelberg Myeloma Center, Heidelberg University Hospital, National Centre for Tumor Diseases (NCT), Heidelberg, Germany., Mai EK; Medical Department V, Heidelberg Myeloma Center, Heidelberg University Hospital, National Centre for Tumor Diseases (NCT), Heidelberg, Germany., Müller-Tidow C; Medical Department V, Heidelberg University Hospital, Heidelberg, Germany., Weinhold N; Medical Department V, Heidelberg Myeloma Center, Heidelberg University Hospital, Germany., Hegenbart U; Medical Department V, Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany., Huhn S; Medical Department V, Heidelberg Myeloma Center, Heidelberg University Hospital, Germany., Schönland SO; Medical Department V, Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany.
Publikováno v:
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis [Amyloid] 2024 Jun; Vol. 31 (2), pp. 86-94. Date of Electronic Publication: 2024 Jan 11.
Autor:
Wennmann M; Division of Radiology, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany.; Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany., Rotkopf LT; Division of Radiology, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany., Bauer F; Division of Radiology, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany., Hielscher T; Division of Biostatistics, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany., Kächele J; Division of Medical Image Computing, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner Site Heidelberg, Heidelberg, Germany., Mai EK; Heidelberg Myeloma Center, Department of Medicine, University Hospital Heidelberg, Heidelberg, Germany., Weinhold N; Heidelberg Myeloma Center, Department of Medicine, University Hospital Heidelberg, Heidelberg, Germany., Raab MS; Heidelberg Myeloma Center, Department of Medicine, University Hospital Heidelberg, Heidelberg, Germany., Goldschmidt H; Heidelberg Myeloma Center, Department of Medicine, University Hospital Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany., Weber TF; Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany., Schlemmer HP; Division of Radiology, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany., Delorme S; Division of Radiology, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany., Maier-Hein K; Division of Medical Image Computing, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner Site Heidelberg, Heidelberg, Germany.; Pattern Analysis and Learning Group, Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany., Neher P; Division of Medical Image Computing, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner Site Heidelberg, Heidelberg, Germany.; Pattern Analysis and Learning Group, Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany.
Publikováno v:
Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2024 May 11. Date of Electronic Publication: 2024 May 11.